Apixaban

Apixaban

Apixaban (trade name: Eliquis) is a direct factor Xa inhibitor for the treatment of venous thromboembolic events. Apixaban has been approved by the U.S Food and Drug Administration on March 18, 2014.

Specifications

Product Name:                  Apixaban

Synonyms:                         BMS-562247-01

CAS Number:                     503612-47-3

Molecular Weight:            459.5

Molecular Formula:          C25H25N5O4

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               O=C5N(c4ccc(N3C(=O)c1c(c(nn1c2ccc(OC)cc2)C(=O)N)CC3)cc4)CCCC5

  • $120.00
  • Ex Tax: $120.00

Available Options